Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study

Hiroyuki Shimada, Akihiro Watanabe, Masaki Ito, Chikako Tono, Haruko Shima, Yuki Yuza, Hideki Muramatsu, Masahiko Okada, Akihiko Tanizawa

Blood (2021) 138 (Supplement 1): 3605.

https://doi.org/10.1182/blood-2021-154335

Published: 2021

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, MD PhD, Akiko Kada, MPH, Akihiko Tanizawa, MD PhD, Yuki Yuza, MD PhD, Akihiro Watanabe, Masaki Ito, MD, Hideko Uryu, Katsuyoshi Koh, MD, Chihaya Imai, MD PhD, Nao Yoshida, MD PhD, Yuhki Koga, MD, Naoto Fujita, MD PhD, Akiko M Saito, MD PhD, Souichi Adachi, MD PhD, Eiichi Ishii, MD PhD, Hiroyuki Shimada, MD PhD

Blood (2019) 134 (Supplement_1): 25.

https://doi.org/10.1182/blood-2019-122623

Published: 2019

Journal Articles

A Novel PAX5-KIDINS220 Fusion Protein Activates Multiple Signals Associated with Therapeutic Resistance

Takuyo Kanayama, MD, Toshihiko Imamura, MD PhD, Kenichi Sakamoto, MD PhD, Fumihiko Hayakawa, MD, PhD, Akihiko Tanizawa, MD PhD, Nobutaka Kiyokawa, MD PhD, Hajime Hosoi, MD PhD

Blood (2018) 132 (Supplement 1): 3928.

https://doi.org/10.1182/blood-2018-99-116022

Published: 2018

Journal Articles

Reduced-Intensity Allogeneic HSCT for Children and Adolescents/Young Adults with CML: A Study from the Adult and Pediatric CML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Hiroyuki Shimada, MD PhD, Akihiko Tanizawa, MD PhD, Takeshi Kondo, MD PhD, Hideki Muramatsu, MD PhD, Masahiro Yasui, MD, Arinobu Tojo, MD PhD, Tokiko Nagamura-Inoue, MD PhD, Tetsuya Eto, MD PhD, Aiko Igarashi, MD, Heiwa Kanamori, MD PhD, Maho Sato, MD, Maiko Noguchi, MD, Tatsuo Ichinohe, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Kazuteru Ohashi, MD PhD

Blood (2018) 132 (Supplement 1): 3008.

https://doi.org/10.1182/blood-2018-99-117836

Published: 2018

Journal Articles

Interim Analysis of a Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study

Hiroyuki Shimada, MD PhD, Hidemitsu Kurosawa, MD, Akihiro Watanabe, Masaki Ito, Chikako Tono, Haruko Shima, MD PhD, Yuki Yuza, MD PhD, Hideki Muramatsu, MD PhD, Noriko Hotta, Masahiko Okada, Akihiko Tanizawa

Blood (2015) 126 (23): 2782.

https://doi.org/10.1182/blood.V126.23.2782.2782

Published: 2015

Journal Articles

Spontaneous Alleviation Of Growth Impairment In Tyrosine Kinase Inhibitor-Treated Chronic Myeloid Leukemia Children

Haruko Shima, MD, PhD, Akihiko Tanizawa, Chikako Tono, Akihiro Watanabe, MD, Hidemitsu Kurosawa, MD, Masaki Ito, MD, PhD, Yuki Yuza, MD, Noriko Hotta, Hideki Muramatsu, MD, PhD, Masahiko Okada, Mika Tokuyama, Koji Kato, MD, Katsuyoshi Koh, MD, PhD, Akiko M. Saito, MD, PhD, Souichi Adachi, MD, PhD, Keizo Horibe, MD, PhD, Shuki Mizutani, MD, PhD, Hiroyuki Shimada, MD, PhD

Blood (2013) 122 (21): 3999.

https://doi.org/10.1182/blood.V122.21.3999.3999

Published: 2013

Journal Articles

Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia

Haruko Shima, MD, PhD, Mika Tokuyama, Akihiko Tanizawa, Chikako Tono, Kazuko Hamamoto, Hideki Muramatsu, Akihiro Watanabe, Noriko Hotta, Masaki Ito, Hidemitsu Kurosawa, MD, Koji Kato, MD, PhD, Masahito Tsurusawa, MD, Keizo Horibe, MD, PhD, Hiroyuki Shimada

Blood (2010) 116 (21): 2277.

https://doi.org/10.1182/blood.V116.21.2277.2277

Published: 2010

Journal Articles

Improved Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) with Induction Failure Treated on the Japan Association of Childhood Leukemia Study (JACLS) ALL F-Protocol.

Nobuhiro Suzuki, Keiko Yumura-Yagi, Junichi Hara, Makoto Yoshida, Shinichiro Nishimura, Tooru Kudoh, Akio Tawa, Ikuya Usami, Akihiko Tanizawa, Hiroki Hori, Yasuhiro Ito, Ryosuke Miyaji, Yoshihiro Komada, Megumi Oda, Keizo Horibe

Blood (2006) 108 (11): 1886.

https://doi.org/10.1182/blood.V108.11.1886.1886

Published: 2006

Journal Articles

Effective Risk-Adapted Therapy for Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL) with the Japan Association of Childhood Leukemia Study (JACLS) ALL-97 Protocol.

Keizo Horibe, MD, Tooru Kudoh, MD, Hiroki Hori, MD, Shinichiro Nishimura, MD, Megumi Oda, MD, Makoto Yoshida, MD, Yoshihiro Komada, MD, Junichi Hara, MD, Akio Tawa, MD, Ikuya Usami, MD, Akihiko Tanizawa, MD, Keiko Yumura-Yagi, MD

Blood (2006) 108 (11): 1874.

https://doi.org/10.1182/blood.V108.11.1874.1874

Published: 2006

Journal Articles

Effective Control of Epstein-Barr Virus–Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy

Blood (1999) 93 (6): 1869–1874.

https://doi.org/10.1182/blood.V93.6.1869.406a31_1869_1874

Published: 1999

NARROW

A Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

A Novel PAX5-KIDINS220 Fusion Protein Activates Multiple Signals Associated with Therapeutic Resistance

Reduced-Intensity Allogeneic HSCT for Children and Adolescents/Young Adults with CML: A Study from the Adult and Pediatric CML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Interim Analysis of a Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study

Spontaneous Alleviation Of Growth Impairment In Tyrosine Kinase Inhibitor-Treated Chronic Myeloid Leukemia Children

Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia

Improved Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) with Induction Failure Treated on the Japan Association of Childhood Leukemia Study (JACLS) ALL F-Protocol.

Effective Risk-Adapted Therapy for Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL) with the Japan Association of Childhood Leukemia Study (JACLS) ALL-97 Protocol.

Effective Control of Epstein-Barr Virus–Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only